By Kelly A. Briganti, Editorial Director, G2 Intelligence
Each year, the U.S. Department of Health and Human Services' Office of Inspector General's (OIG's) Work Plan highlights the projects and reviews it will pursue in the coming year. At the end of May, the OIG released an update adding new activities to that agenda. This latest update added one item directly addressing clinical…
Read more...
By Ron Shinkman, Editor, Laboratory Industry Report
The Chronic Liver Disease Foundation has teamed up with retail giant Walgreens to offer free testing for hepatitis C at the latter's drugstores.
The testing will start this August and will run through January 2016 at various times and days of the week. It will be offered at more than five dozen Walgreens locations in 12 major cities throughout the …
Read more...
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Contrary to wide-held belief, there is nothing exceptional about genomic medicine that would preclude physicians from readily incorporating genetic assessment and testing into routine clinical care, according to a focus piece published May 13 in Science Translational Medicine…
Read more...
By Stephanie Murg, Managing Director, G2 Intelligence
A precision medicine approach is yielding valuable new insights into a common, aggressive form of prostate cancer. Researchers sequenced the DNA and RNA of tumor biopsy samples from 150 men with metastatic, castration-resistant prostate cancer (mCRPC), an advanced cancer that has stopped responding to standard hormone-based therapies, to conduct the first major analysis of this type of cancer in…
Read more...
By Kelly A. Briganti, Editorial Director, G2 Intelligence
Prostate cancer testing has received significant attention lately as the industry seeks to find reliable ways of identifying the appropriate treatment strategy for patients diagnosed with such cancer. A new draft local coverage decision proposed by Medicare Administrative Contractor Palmetto GBA notes that "[i]n 2014, nearly 233,000 men in the US will be diagnosed with prostate cancer, which accounts for 14% of all new cancers." The Centers for Disease Control and Prevention (CDC) indicates that…
Read more...
|
